UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
about
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@en
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@nl
type
label
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@en
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@nl
prefLabel
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@en
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@nl
P2093
P50
P1476
UPLC-MS/MS method for the simu ...... HIV/HCV co-infected patients.
@en
P2093
Adriana Ammassari
Gabriele Fabbri
Raffaella Libertone
Stefania Notari
P304
P356
10.1016/J.JCHROMB.2017.12.018
P577
2017-12-12T00:00:00Z